Presentation TCT 2018

EWOLUTION: Two-Year Efficacy of Left Atrial Appendage Closure in High-Risk Patients - Single Antiplatelet/No Therapy Subgroup Analysis

Presenter: Martin W. Bergmann

September 23, 2018

REGISTER for free or LOG IN to view this content

EWOLUTION: Two-Year Efficacy of Left Atrial Appendage Closure in High-Risk Patients - Single Antiplatelet/No Therapy Subgroup Analysis

Structural Heart

Presentation

TCT 2018

Left Atrial Appendage

Up Next

Presentation TCT 2018

TAVI/LAAO: A Randomized Trial of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

Presenter: Fabian Nietlispach

September 23, 2018

More slides +

Presentation TCT 2018

OBSERVANT: Five-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in a Low/Intermediate-Risk Real-world Population

Presenter: Marco Barbanti

September 23, 2018

Presentation TCT 2018

CENTER-Collaboration I: Nonrandomized Comparison of Transcatheter Aortic Valve Implantation With Balloon-Expandable Valves vs Self-Expandable Valves

Presenter: Ronak Delewi

September 23, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.